NCT03766594View on ClinicalTrials.gov

Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

November 20, 2018

Study Completion Date

December 1, 2018

Conditions

Miscarriage, Recurrent

Interventions

DRUG

Sildenafil Citrate

Respatio(R) 25mg tablets four times daily for 24 days preconceptionally starting first day of previous period

DRUG

Folic Acid

Folic acid(R) 0.5mg tablets once daily for 3 months preconceptionally

DRUG

Placebo Oral Tablet

Placebo tablet apparently identical to Respatio(R) 25mg tablets, taken four times daily for 24 days preconceptionally starting first day of previous period

Trial Locations (1)

002

Ain SHams Maternity Hospital, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT03766594 - Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss | Biotech Hunter | Biotech Hunter